Clearmind Medicine Inc. Common Shares (CMND) — Financial Flexibility Index
Clearmind Medicine Inc. Common Shares (CMND) has a Financial Flexibility Index of -0.72x as of January 2026. Free cash flow of $-2.08 Million (operating CF $-2.08 Million minus capex $0.00) represents -1% of total liabilities ($2.90 Million). Check CMND total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Clearmind Medicine Inc. Common Shares Financial Flexibility Index (2014–2025)
Historical Financial Flexibility Index trend for Clearmind Medicine Inc. Common Shares across 12 annual periods. For the full cash flow conversion analysis, see CMND cash flow conversion.
Annual Financial Flexibility Index for Clearmind Medicine Inc. Common Shares (2014–2025)
Year-by-year free cash flow to debt coverage for Clearmind Medicine Inc. Common Shares. Explore how well can Clearmind Medicine Inc. Common Shares service its debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.97x | $-4.73 Million | $-4.73 Million | $4.89 Million | ▲ +17.4% |
| 2024 | -1.17x | $-6.76 Million | $-6.76 Million | $5.77 Million | ▲ +7.6% |
| 2023 | -1.27x | $-6.30 Million | $-6.30 Million | $4.97 Million | ▲ +34.1% |
| 2022 | -1.92x | $-5.05 Million | $-5.06 Million | $2.62 Million | ▲ +70.9% |
| 2021 | -6.62x | $-1.91 Million | $-2.08 Million | $288.19K | ▲ +65.2% |
| 2020 | -19.04x | $-191.00K | $-198.50K | $10.03K | ▼ -1501.0% |
| 2019 | -1.19x | $-40.26K | $-47.85K | $33.85K | ▼ -135.5% |
| 2018 | 3.35x | $19.50K | $-80.48K | $5.83K | ▲ +1746.4% |
| 2017 | 0.18x | $9.30K | $-9.12K | $51.28K | ▲ +159.0% |
| 2016 | -0.31x | $-15.37K | $-15.37K | $50.01K | ▲ +83.2% |
| 2015 | -1.83x | $-39.81K | $-39.81K | $21.76K | ▼ -105.2% |
| 2014 | -0.89x | $-28.01K | $-28.01K | $31.43K | — |